EUVIMEDEUVIMED entdecken
Crossref

Alternative Splicing and Proteoform Diversity in Cancer: Connecting Molecular Genetics, Proteomics, and Therapeutic Vulnerabilities

Klaus Schmidt, Anna Fischer, Dieter Müller

Journal of Biochemical Technology · 2026 · 17 (4) · 116-124

DOI: 10.51847/uj649brdma ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical Technology, 2026. Verfasst von Klaus Schmidt und 2 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Schmidt, K., Fischer, A., & Müller, D. (2026). Alternative Splicing and Proteoform Diversity in Cancer: Connecting Molecular Genetics, Proteomics, and Therapeutic Vulnerabilities. Journal of Biochemical Technology, 17(4), 116-124. https://doi.org/10.51847/uj649brdma

Vancouver

Schmidt K, Fischer A, Müller D. Alternative Splicing and Proteoform Diversity in Cancer: Connecting Molecular Genetics, Proteomics, and Therapeutic Vulnerabilities. Journal of Biochemical Technology. 2026;17(4):116-124. doi:10.51847/uj649brdma

BibTeX
@article{Schmidt2026,
  author = {Schmidt, Klaus and Fischer, Anna and Müller, Dieter},
  title = {Alternative Splicing and Proteoform Diversity in Cancer: Connecting Molecular Genetics, Proteomics, and Therapeutic Vulnerabilities},
  journal = {Journal of Biochemical Technology},
  year = {2026},
  volume = {17},
  number = {4},
  pages = {116--124},
  doi = {10.51847/uj649brdma}
}
Kostenlos starten →